EFEMP1 is associated with decreased MMP-2 and MMP-7 levels in lung cancer [17] and MMP-2 and MMP-9 levels in endometrial carcinoma [28], which are also observed in highly metastasizing and rapidly expanding tumors. Here, MMP9 is linked to endometrial carcinoma.